XML 19 R6.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Stockholders' (Deficit)/Equity - USD ($)
Common Stock [Member]
Treasury Stock [Member]
Paid-in Capital [Member]
Accumulated Deficit [Member]
Total Stockholders’ (Deficit)/ Equity [Member]
Noncontrolling Interest [Membet]
Total
Balance at Dec. 31, 2023 $ 8,800 $ 0 $ 0 $ (66,770,700) $ (66,761,900) $ 0 $ (66,761,900)
Balance (in Shares) at Dec. 31, 2023 87,500,000            
Balance (in Shares) at Dec. 31, 2023   0          
Fair value of TMTG earnout shares $ 0 $ 0 2,477,550,200 (2,477,550,200) 0 0 0
Conversion of convertible notes upon reverse capitalization $ 600 $ 0 300,425,400 0 300,426,000 0 300,426,000
Conversion of convertible notes upon reverse capitalization (in Shares) 6,014,534 0          
Stock based compensation $ 200 $ 0 84,587,800 0 84,588,000 0 84,588,000
Stock based compensation (in Shares) 1,840,000 0          
Issuance of common stock upon reverse capitalization $ 4,100 $ 0 219,617,500 0 219,621,600 0 219,621,600
Issuance of common stock upon reverse capitalization (in Shares) 41,346,049 0          
Net loss $ 0 $ 0 0 (327,599,700) (327,599,700) 0 (327,599,700)
Balance at Mar. 31, 2024 $ 13,700 $ 0 3,082,180,900 (2,871,920,600) 210,274,000 0 210,274,000
Balance (in Shares) at Mar. 31, 2024 136,700,583            
Balance (in Shares) at Mar. 31, 2024   0          
Balance at Dec. 31, 2023 $ 8,800 $ 0 0 (66,770,700) (66,761,900) 0 (66,761,900)
Balance (in Shares) at Dec. 31, 2023 87,500,000            
Balance (in Shares) at Dec. 31, 2023   0          
Net loss             (363,216,100)
Balance at Sep. 30, 2024 $ 21,500 $ (2,908,700) 3,726,957,300 (2,907,537,000) 816,533,100 0 816,533,100
Balance (in Shares) at Sep. 30, 2024 214,517,760            
Balance (in Shares) at Sep. 30, 2024   (128,138)          
Balance at Mar. 31, 2024 $ 13,700 $ 0 3,082,180,900 (2,871,920,600) 210,274,000 0 210,274,000
Balance (in Shares) at Mar. 31, 2024 136,700,583            
Balance (in Shares) at Mar. 31, 2024   0          
Exercise of warrants $ 900 $ 0 97,761,400 0 97,762,300 0 97,762,300
Exercise of warrants (in Shares) 8,526,792            
Exercise of warrants (in Shares)   0          
Issuance of earnout shares $ 4,000 $ 0 (4,000) 0 0 0 0
Issuance of earnout shares (in Shares) 40,000,000            
Issuance of earnout shares (in Shares)   0          
Conversion of convertible notes into common stock $ 600 $ 0 49,999,400 0 50,000,000 0 50,000,000
Conversion of convertible notes into common stock (in Shares) 6,250,000            
Conversion of convertible notes into common stock (in Shares)   0          
Net loss $ 0 $ 0 0 (16,368,000) (16,368,000) 0 (16,368,000)
Balance at Jun. 30, 2024 $ 19,200 $ 0 3,229,937,700 (2,888,288,600) 341,668,300 0 341,668,300
Balance (in Shares) at Jun. 30, 2024 191,477,375            
Balance (in Shares) at Jun. 30, 2024   0          
Exercise of warrants $ 200 $ 0 20,222,600 0 20,222,800 0 20,222,800
Exercise of warrants (in Shares) 1,758,501            
Exercise of warrants (in Shares)   0          
Common stock issued from SEPA $ 1,700 $ 0 344,742,500 0 344,744,200 0 344,744,200
Common stock issued from SEPA (in Shares) 17,655,365 0          
Acquisition of WCT, net of offering costs $ 300 $ 0 132,009,100 0 132,009,400 0 132,009,400
Acquisition of WCT, net of offering costs (in Shares) 2,600,000 0          
Issuance of common stock for services $ 0 $ 0 45,500 0 45,500 0 45,500
Issuance of common stock for services (in Shares) 2,002 0          
Treasury stock $ 0 $ (2,908,700) 0 0 (2,908,700) 0 (2,908,700)
Treasury stock (in Shares)   (128,138)          
Common stock for ARC settlement $ 100 $ 0 (100) 0 0 0  
Common stock for ARC settlement (in Shares) 1,024,517            
Common stock for ARC settlement (in Shares)   0          
Net loss $ 0 $ 0 0 (19,248,400) (19,248,400) 0 (19,248,400)
Balance at Sep. 30, 2024 $ 21,500 $ (2,908,700) 3,726,957,300 (2,907,537,000) 816,533,100 0 816,533,100
Balance (in Shares) at Sep. 30, 2024 214,517,760            
Balance (in Shares) at Sep. 30, 2024   (128,138)          
Balance at Dec. 31, 2024 $ 22,100 $ (2,908,700) 3,861,662,400 (2,945,185,700) 913,590,100 0 $ 913,590,100
Balance (in Shares) at Dec. 31, 2024 220,785,152            
Balance (in Shares) at Dec. 31, 2024   (128,138)         (128,138)
Stock based compensation $ 0 $ 0 17,851,700 0 17,851,700 0 $ 17,851,700
Stock based compensation (in Shares) 0 0          
Exercise of warrants $ 0 $ 0 221,500 0 221,500 0 221,500
Exercise of warrants (in Shares) 19,292            
Exercise of warrants (in Shares)   0          
Treasury stock $ 0 $ (8,250,200) 0 0 (8,250,200) 0 (8,250,200)
Treasury stock (in Shares)   (296,345)          
Vesting of restricted stock units $ 0 $ 0 0 0 0 0 0
Vesting of restricted stock units (in Shares) 243,411 0          
Net loss $ 0 $ 0 0 (31,726,600) (31,726,600) 0 (31,726,600)
Balance at Mar. 31, 2025 $ 22,100 $ (11,158,900) 3,879,735,600 (2,976,912,300) 891,686,500 0 891,686,500
Balance (in Shares) at Mar. 31, 2025 221,047,855            
Balance (in Shares) at Mar. 31, 2025   (424,483)          
Balance at Dec. 31, 2024 $ 22,100 $ (2,908,700) 3,861,662,400 (2,945,185,700) 913,590,100 0 $ 913,590,100
Balance (in Shares) at Dec. 31, 2024 220,785,152            
Balance (in Shares) at Dec. 31, 2024   (128,138)         (128,138)
Net loss             $ (106,577,000)
Balance at Sep. 30, 2025 $ 28,100 $ (17,571,500) 5,347,340,200 (3,051,702,700) 2,278,094,100 190,000 $ 2,278,284,100 [1]
Balance (in Shares) at Sep. 30, 2025 280,777,274            
Balance (in Shares) at Sep. 30, 2025   (779,691)         (779,691) [1]
Balance at Mar. 31, 2025 $ 22,100 $ (11,158,900) 3,879,735,600 (2,976,912,300) 891,686,500 0 $ 891,686,500
Balance (in Shares) at Mar. 31, 2025 221,047,855            
Balance (in Shares) at Mar. 31, 2025   (424,483)          
Stock based compensation $ 0 $ 0 17,744,600 0 17,744,600 0 17,744,600
Stock based compensation (in Shares) 0 0          
Common stock issued in PIPE $ 5,600 $ 0 1,392,401,400 0 1,392,407,000 0 1,392,407,000
Common stock issued in PIPE (in Shares) 55,857,181            
Common stock issued in PIPE (in Shares)   0          
Exercise of warrants $ 0 $ 0 42,100 0 42,100 0 42,100
Exercise of warrants (in Shares) 3,659            
Exercise of warrants (in Shares)   0          
Vesting of restricted stock units $ 100 $ 0 (100) 0 0 0 0
Vesting of restricted stock units (in Shares) 825,981 0          
Non-controlling interest contribution $ 0 $ 0 0 0 0 250,000 250,000
Net loss 0 0 0 (19,982,300) (19,982,300) (19,600) (20,001,900)
Balance at Jun. 30, 2025 $ 27,800 $ (11,158,900) 5,289,923,600 (2,996,894,600) 2,281,897,900 230,400 2,282,128,300
Balance (in Shares) at Jun. 30, 2025 277,734,676            
Balance (in Shares) at Jun. 30, 2025   (424,483)          
Stock based compensation $ 0 $ 0 10,490,200 0 10,490,200 0 10,490,200
Stock based compensation (in Shares) 0 0          
Exercise of warrants $ 0 $ 0 32,500 0 32,500 0 32,500
Exercise of warrants (in Shares) 2,828            
Exercise of warrants (in Shares)   0          
Treasury stock $ 0 $ (6,412,600) 0 0 (6,412,600) 0 (6,412,600)
Treasury stock (in Shares)   (355,208)          
Vesting of restricted stock units $ 0 $ 0 0 0 0 0 0
Vesting of restricted stock units (in Shares) 241,785 0          
Common stock issued to purchase digital assets $ 300   46,893,900 0 46,894,200 0 46,894,200
Common stock issued to purchase digital assets (in Shares) 2,797,985 0          
Net loss $ 0 $ 0 0 (54,808,100) (54,808,100) (40,400) (54,848,500)
Balance at Sep. 30, 2025 $ 28,100 $ (17,571,500) $ 5,347,340,200 $ (3,051,702,700) $ 2,278,094,100 $ 190,000 $ 2,278,284,100 [1]
Balance (in Shares) at Sep. 30, 2025 280,777,274            
Balance (in Shares) at Sep. 30, 2025   (779,691)         (779,691) [1]
[1] Under certain provisions of Accounting Standards Codification (“ASC”) 810, Consolidations, (“ASC 810”) we are required to separately disclose on our condensed consolidated balance sheets the assets of the consolidated variable interest entity (“VIE”) that are owned by the consolidated VIE and liabilities of the consolidated VIE as to which there is no recourse against us.